-
USD
PEG MGF*10vials
-
Detail
PEG-MGF (Pegylated Mechano Growth Factor) is a long-acting, pegylated form of Mechano Growth Factor (MGF / IGF-1Ec). The covalent attachment of a 20–30 kDa linear or branched PEG chain to the N-terminus of the native MGF peptide significantly extends plasma half-life from minutes (native MGF) to several days, while maintaining structural integrity. This modification enables systemic delivery with sustained exposure, making PEG-MGF a useful tool in preclinical research models requiring prolonged compound availability. First described in 2004–2006 as a structural improvement over native MGF, PEG-MGF is a preferred isoform in various laboratory research contexts. This research-grade lyophilized peptide is synthesized under strict quality controls and provided with full analytical documentation.
Key Scientific Characteristics
- High-purity PEG-MGF (≥ 98% by HPLC/SEC, acetate salt form)
- Verified 24-amino-acid MGF sequence with site-specific 20–30 kDa PEG conjugation
- Lyophilized formulation for maximum long-term stability
- Full Certificate of Analysis (COA) with HPLC, SEC (size-exclusion), MALDI-TOF MS (PEG confirmation), and bioactivity assay
- Manufactured in GMP-aligned, ISO-compliant facilities
Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)
- Half-life extended from minutes to days via PEG shielding from proteolytic degradation, as described in preclinical literature
- Structurally superior to native MGF for systemic distribution in whole-body or contralateral tissue research models
- Studied in various preclinical in vitro and in vivo contexts, including skeletal muscle, cardiac, and neurological research models — see for referenced literature
- Legal status: Research compound only; not FDA-approved for any therapeutic use — see
-
Customer ReviewsNo comments